Zhao C - Search Results

1

Incorporating the Number of PLN into the AJCC Stage Could Better Predict the Survival for Patients with NSCLC: A Large Population-Based Study.

Shang X, Li Z, Lin J, Yu H, Zhao C, Wang H, Sun J. Shang X, et al. Among authors: zhao c. J Oncol. 2020 Dec 11;2020:1087237. doi: 10.1155/2020/1087237. eCollection 2020. J Oncol. 2020. PMID: 33381175 Free PMC article.

2

Different distant metastasis patterns based on tumor size could be found in extensive-stage small cell lung cancer patients: a large, population-based SEER study.

Li J, Liu F, Yu H, Zhao C, Li Z, Wang H. Li J, et al. Among authors: zhao c. PeerJ. 2019 Dec 3;7:e8163. doi: 10.7717/peerj.8163. eCollection 2019. PeerJ. 2019. PMID: 31824772 Free PMC article.

3

A Novel Nomogram including AJCC Stages Could Better Predict Survival for NSCLC Patients Who Underwent Surgery: A Large Population-Based Study.

Shang X, Yu H, Lin J, Li Z, Zhao C, Sun J, Wang H. Shang X, et al. Among authors: zhao c. J Oncol. 2020 May 20;2020:7863984. doi: 10.1155/2020/7863984. eCollection 2020. J Oncol. 2020. PMID: 32565807 Free PMC article.

4

Comprehensive analysis of multiple parameters associated with tumor immune microenvironment in ARID1A mutant cancers.

Li Z, Lin J, Zhang L, Li J, Zhang Y, Zhao C, Wang H. Li Z, et al. Among authors: zhao c. Future Oncol. 2020 Oct;16(29):2295-2306. doi: 10.2217/fon-2020-0243. Epub 2020 Jul 8. Future Oncol. 2020. PMID: 32639175

5

PDL1 high expression without TP53, KEAP1 and EPHA5 mutations could better predict survival for patients with NSCLC receiving atezolizumab.

Wang H, Shan Q, Guo J, Han X, Zhao C, Li H, Wang Z. Wang H, et al. Among authors: zhao c. Lung Cancer. 2021 Jan;151:76-83. doi: 10.1016/j.lungcan.2020.11.006. Epub 2020 Nov 13. Lung Cancer. 2021. PMID: 33246647

6

CD44, a marker of cancer stem cells, is positively correlated with PD-L1 expression and immune cells infiltration in lung adenocarcinoma.

Zhang C, Wang H, Wang X, Zhao C, Wang H. Zhang C, et al. Among authors: zhao c. Cancer Cell Int. 2020 Dec 7;20(1):583. doi: 10.1186/s12935-020-01671-4. Cancer Cell Int. 2020. PMID: 33372595 Free PMC article.

7

Survival analysis for non-squamous NSCLC patients harbored STK11 or KEAP1 mutation receiving atezolizumab.

Shang X, Li Z, Sun J, Zhao C, Lin J, Wang H. Shang X, et al. Among authors: zhao c. Lung Cancer. 2021 Apr;154:105-112. doi: 10.1016/j.lungcan.2021.02.010. Epub 2021 Feb 17. Lung Cancer. 2021. PMID: 33640623

8

A 5-Genomic Mutation Signature Can Predict the Survival for Patients With NSCLC Receiving Atezolizumab.

Lin J, Wang X, Zhang C, Bu S, Zhao C, Wang H. Lin J, et al. Among authors: zhao c. Front Immunol. 2021 Jun 23;12:606027. doi: 10.3389/fimmu.2021.606027. eCollection 2021. Front Immunol. 2021. PMID: 34248926 Free PMC article. Clinical Trial.

9

A clinical variable-based nomogram could predict the survival for advanced NSCLC patients receiving second-line atezolizumab.

Shang X, Shi J, Wang X, Zhao C, Yu H, Wang H. Shang X, et al. Among authors: zhao c. Cancer Med. 2021 Sep;10(18):6218-6226. doi: 10.1002/cam4.4160. Epub 2021 Jul 31. Cancer Med. 2021. PMID: 34331414 Free PMC article.

10

Genetic alternations and immune characteristics in patients with small cell lung cancer.

Zhang C, Zhao C, Wang H. Zhang C, et al. Among authors: zhao c. Cancer Commun (Lond). 2021 Oct;41(10):1075-1078. doi: 10.1002/cac2.12208. Epub 2021 Aug 24. Cancer Commun (Lond). 2021. PMID: 34427988 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,324 results

Search Page

Filters